330 related articles for article (PubMed ID: 3917924)
21. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract][Full Text] [Related]
22. Alteration of macrophage cytotoxicity through endogenous interferon and tumor necrosis factor alpha induction by propanil.
Theus SA; Tabor DR; Gandy J; Barnett JB
Toxicol Appl Pharmacol; 1993 Jan; 118(1):46-52. PubMed ID: 7679225
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
25. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
26. Distinction of B cell maturation factors from lymphokines affecting B cell growth and viability.
Sherris DI; Sidman CL
J Immunol; 1986 Feb; 136(3):994-8. PubMed ID: 3079808
[TBL] [Abstract][Full Text] [Related]
27. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background.
McKisic MD; Lancki DW; Fitch FW
J Immunol; 1993 May; 150(9):3793-805. PubMed ID: 8097225
[TBL] [Abstract][Full Text] [Related]
28. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
29. gamma-Interferon plays a key role in T-cell-induced tumor regression.
Tuttle TM; McCrady CW; Inge TH; Salour M; Bear HD
Cancer Res; 1993 Feb; 53(4):833-9. PubMed ID: 8428364
[TBL] [Abstract][Full Text] [Related]
30. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
Davis CE; Belosevic M; Meltzer MS; Nacy CA
J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
[TBL] [Abstract][Full Text] [Related]
31. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
Meltzer MS; Benjamin WR; Farrar JJ
J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
[TBL] [Abstract][Full Text] [Related]
32. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
Murray HW; Gellene RA; Libby DM; Rothermel CD; Rubin BY
J Immunol; 1985 Oct; 135(4):2374-7. PubMed ID: 3928746
[TBL] [Abstract][Full Text] [Related]
33. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
[TBL] [Abstract][Full Text] [Related]
34. Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction.
Conta BS; Powell MB; Ruddle NH
J Immunol; 1985 Apr; 134(4):2185-90. PubMed ID: 2579131
[TBL] [Abstract][Full Text] [Related]
35. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
[TBL] [Abstract][Full Text] [Related]
36. Macrophage antitumor activity: impaired responsiveness to interferon-gamma of macrophages from genetically defective mice.
Boraschi D; Censini S; Tagliabue A
Eur J Immunol; 1984 Nov; 14(11):1061-3. PubMed ID: 6437846
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
38. Anti-proliferative effect of IFN-gamma in immune regulation. IV. Murine CTL clones produce IL-3 and GM-CSF, the activity of which is masked by the inhibitory action of secreted IFN-gamma.
Gajewski TF; Fitch FW
J Immunol; 1990 Jan; 144(2):548-56. PubMed ID: 2104898
[TBL] [Abstract][Full Text] [Related]
39. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
Gajewski TF; Goldwasser E; Fitch FW
J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
[TBL] [Abstract][Full Text] [Related]
40. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
Kornbluth RS; Gregory SA; Edgington TS
J Immunol; 1988 Sep; 141(6):2006-15. PubMed ID: 3139748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]